Michael R. O’Donovan

A rationale for determining, testing, and controlling specific impurities in pharmaceuticals that possess potential for genotoxicity

Lutz Müller, Robert J. Mauthe, Christopher M. Riley et al. · Regulatory Toxicology and Pharmacology · 2006 · 461 citations

Pharmacy, Pharmaceutics, Toxicology +12

Acceptability and accuracy of a non-endoscopic screening test for Barrett's oesophagus in primary care: cohort study

Sudarshan Kadri, Pierre Lao‐Sirieix, Michael R. O’Donovan et al. · BMJ · 2010 · 319 citations · Full text

Medicine, Clinical Sciences, Cancer Screening +15

Mouse lymphoma thymidine kinase gene mutation assay: Follow‐up meeting of the international workshop on Genotoxicity testing—Aberdeen, Scotland, 2003—Assay acceptance criteria, positive controls, and data evaluation

Martha M. Moore, Masamitsu Honma, Julie Clements et al. · Environmental and Molecular Mutagenesis · 2005 · 143 citations

Pharmacy, Oncology, Cancer Genetics +15

Subcellular compartmentalization of glutathione: Correlations with parameters of oxidative stress related to genotoxicity

Richard M. Green, M. Graham, Michael R. O’Donovan et al. · Mutagenesis · 2006 · 118 citations · Full text

Life Sciences, Biochemistry, Cell Biology +17

Mouse Lymphoma Thymidine Kinase Gene Mutation Assay: International Workshop on Genotoxicity Tests Workgroup Report—Plymouth, UK 2002

Martha M. Moore, Masamitsu Honma, Julie Clements et al. · Mutation Research/Genetic Toxicology and Environmental Mutagenesis · 2003 · 85 citations

Pharmacy, Oncology, Toxicology +12